Drägerwerk stock: Berenberg sees margin upside ahead of 2028
Published on 11/13/2026 at 17:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSMargin outlook gains attention
- Berenberg sees operating leverage in Safety Technology and a later recovery in Medical Technology.
- The analyst expects its 2027 and 2028 earnings estimates to exceed consensus by 14 percent.
- Dräger's Capital Markets Day in Lübeck is scheduled for November 18, 2026.
Drägerwerk stock is entering a new analyst spotlight after Berenberg initiated coverage on November 11 with a Buy rating and a 156 euro price target. The assessment, reported by Investing.com, centers on a margin-focused strategy at the medical and safety equipment maker.
Safety division leads the case
Berenberg expects Safety Technology to provide the stronger near-term operating contribution. The bank points to improved operations after supply-chain disruptions, supported by pricing, procurement and lean-management measures.
The research firm projects compound annual EBIT growth of 12.3 percent through 2028. It sees the group EBIT margin rising from 6.7 percent in 2025 to 8.4 percent in 2028, while annual sales growth is forecast at 5.2 percent from 2026 through 2028.
Medical recovery remains later
Berenberg expects Medical Technology to recover from 2028. The case rests on a richer product mix, manufacturing efficiencies and the lifting of a US Food and Drug Administration warning letter, which reopens the US patient-monitoring market according to the report.
The bank's earnings estimates are 14 percent above consensus for 2027 and 2028. It models an 8.7 percent EBIT margin for 2030, below management's 10 percent target, leaving the Capital Markets Day as an important upcoming test for the longer-term margin plan.
Next strategy milestone
Dräger's official financial calendar lists the Capital Markets Day for November 18, 2026, in Lübeck. Management is expected to present its Ambition 2030 strategy at the event, giving investors a closer look at growth priorities and margin targets.
Drägerwerk stock at a glance
- Company: Drägerwerk AG & Co. KGaA
- ISIN: DE0005550636
- Analyst view: Berenberg Buy rating
- Price target: 156 euros
- Strategy event: Capital Markets Day on November 18, 2026, in Lübeck
Broader European context is available in Current market reports.
